Medical Transcription Billing (NASDAQ:MTBC) is scheduled to be announcing its earnings results before the market opens on Wednesday, August 7th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Medical Transcription Billing has set its FY 2019 guidance at EPS.
Medical Transcription Billing (NASDAQ:MTBC) last issued its quarterly earnings data on Wednesday, May 8th. The technology company reported ($0.15) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.25) by $0.10. The firm had revenue of $15.08 million during the quarter, compared to analysts’ expectations of $14.65 million. Medical Transcription Billing had a negative net margin of 6.22% and a negative return on equity of 10.79%. On average, analysts expect Medical Transcription Billing to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of NASDAQ MTBC opened at $4.65 on Tuesday. The firm has a market capitalization of $55.93 million, a PE ratio of -7.88 and a beta of 1.62. The firm’s 50 day moving average price is $4.80. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.49 and a current ratio of 2.53. Medical Transcription Billing has a 52-week low of $3.25 and a 52-week high of $5.65.
In related news, Director John N. Daly sold 6,600 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $4.88, for a total transaction of $32,208.00. Following the completion of the transaction, the director now owns 119,750 shares in the company, valued at $584,380. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Mahmud Ul Haq sold 179,000 shares of the business’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $5.00, for a total transaction of $895,000.00. Following the transaction, the insider now owns 4,902,070 shares of the company’s stock, valued at approximately $24,510,350. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 186,600 shares of company stock valued at $931,878. Corporate insiders own 50.50% of the company’s stock.
About Medical Transcription Billing
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.